The board of directors of LifeTech Scientific Corporation announced that on 6 February 2023, the company entered into a strategic cooperation agreement with Jenscare Scientific Co., Ltd. (Jenscare Scientific) in respect of potential cooperation including but not limited to business development, project investments and financing in mainland China and overseas. Pursuant to the Strategic Cooperation Agreement, the company and Jenscare Scientific shall explore a long-term and stable strategic cooperation relationship. In particular: 1. the company shall assist Jenscare Scientific in the completion of clinical trials and product registrations in mainland China and overseas; 2. the parties shall cooperate strategically in the sales and marketing of products, including but not limited to in mainland China, Asia Pacific, Europe, North America and Latin America; 3. the parties shall cooperate and assist each other in the research and development of globally innovative products; 4. the parties shall cooperate in the development of a digitalized and automated production supply chain system in the long term; and 5. the parties shall share potential investments and merger and acquisition resources that will help the other party's product strategy, and promote the long term development of the parties.

If the parties agree to cooperate on specific projects in relation to the above areas in the future, the company and Jenscare Scientific will enter into separate agreements which will set out the specific terms and conditions according to the principles under the Strategic Cooperation Agreement.